The experts group stats & facts
Experts
Countries
Publications
Recent updates
The Clinical Use of Myo-Inositol in IVF-ET: A Position Statement from the Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), the Polish Society of Andrology, and the International Scientific Association for the Support and Development of Medical Technologies
Authors: Wdowiak A, Bakalczuk S, Filip M, Laganà AS, Unfer V.

EGOI-PCOS Joins the International Network of FISGE
Authors: EGOI Members
Inositols and Bone Health: Potential Therapeutic Applications in Osteoporosis Prevention and Treatment
Authors: Cipriani, F.; Gnessi, L.; Watanabe, M.; Baldelli, R.
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review.
Authors: Lentini G, Querqui A, Monti N, Bizzarri M.
Insights from the EGOI-PCOS patient survey: Diagnosis, treatment, and quality of life according to Italian PCOS patients
Authors: Carriero VC, Forte G, Dinicola S, Oliva MM, Al Mudarris G., Unfer V.
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
Authors: Myers SH, Soulage CO, Unfer V.
D-chiro-inositol effectively counteracts endometriosis in a mouse model
Authors: Placidi M, Casoli G, Vergara T, Bianchi A, Cocciolone D, Zaccardi S, Macchiarelli G, Palmerini MG, Tatone C, Bevilacqua A, Di Emidio G.
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases
Authors: Quecchia C, Vianello A.
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora’s box
Authors: Sabrina Basciani, Maurizio Nordio, Maria Letizia Spizzichini and Lucio Gnessi
A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.